Cargando…

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk

IMPORTANCE: Colorectal cancer (CRC) screening reduces CRC incidence and mortality. It is important to examine screening patterns over time, including after the introduction of new screening modalities. OBJECTIVE: To compare use of CRC screening tests before and after the availability of the multitar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisher, Deborah A., Princic, Nicole, Miller-Wilson, Lesley-Ann, Wilson, Kathleen, Fendrick, A. Mark, Limburg, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414191/ https://www.ncbi.nlm.nih.gov/pubmed/34473259 http://dx.doi.org/10.1001/jamanetworkopen.2021.22269

Ejemplares similares

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Colorectal screening among average risk individuals in the United States, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2022)

Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2023)

Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment
por: Heidenreich, Sebastian, et al.
Publicado: (2022)

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020
por: Mohl, Jeff T., et al.
Publicado: (2023)

Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66–75 years in 2016–2018
por: Li, Suying, et al.
Publicado: (2022)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
por: Zhu, Xuan, et al.
Publicado: (2022)

Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014
por: Wright, Jason D., et al.
Publicado: (2021)

Patient Attitudes Toward Individualized Recommendations to Stop Low-Value Colorectal Cancer Screening
por: Piper, Marc S., et al.
Publicado: (2018)

Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population
por: Shepherd, Martha E., et al.
Publicado: (2021)

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Synchronous Neoplasia Rates at Colonoscopic Diagnosis of Early-Onset vs Average-Onset Colorectal Cancer
por: Emiloju, Oluwadunni E., et al.
Publicado: (2023)

Disparities in Recommendations for Colorectal Cancer Screening Among Average-Risk Individuals: An Ecobiosocial Approach
por: Syed Soffian, Sharifah Saffinas, et al.
Publicado: (2022)

Factors Associated With Clinician Recommendations for Colorectal Cancer Screening Among Average-Risk Patients: Data From a National Survey
por: Zhu, Xuan, et al.
Publicado: (2022)

Choosing Subsamples for Sequencing Studies by Minimizing the Average Distance to the Closest Leaf
por: Kang, Jonathan T. L., et al.
Publicado: (2015)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
por: Bosch, L.J.W., et al.
Publicado: (2019)

Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing
por: Barthold, Douglas, et al.
Publicado: (2022)

Evaluation of a multimedia outreach campaign for a multi-target stool DNA test for colorectal cancer screening among non-medicare employer population in the United States
por: Shepherd, Martha E., et al.
Publicado: (2022)

Opportunities and Challenges in Screening for Colorectal Cancer
por: Miller Wilson, Lesley-Ann, et al.
Publicado: (2023)

An Estimate of the Average Number of Recessive Lethal Mutations Carried by Humans
por: Gao, Ziyue, et al.
Publicado: (2015)

Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial
por: Mehta, Shivan J., et al.
Publicado: (2019)

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model
por: Piscitello, Andrew, et al.
Publicado: (2020)

The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer
por: Hawken, Steven J., et al.
Publicado: (2010)

Benefits of Dominance over Additive Models for the Estimation of Average Effects in the Presence of Dominance
por: Duenk, Pascal, et al.
Publicado: (2017)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Average semivariance directly yields accurate estimates of the genomic variance in complex trait analyses
por: Feldmann, Mitchell J, et al.
Publicado: (2022)

Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality
por: Prosper, Ashley E., et al.
Publicado: (2021)

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
por: Tinmouth, Jill, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3fnfcv8nbp8962qd70dbjnctjj